Metpath-GP2 Tablet SR
Marketer
Proqol Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Metpath-GP2 Tablet SR
Glimepiride-Metformin extended-release tablets are a dual-action medication managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin utilization, resulting in reduced blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food mitigates potential gastrointestinal discomfort. For missed doses, take as soon as remembered, unless nearing the next scheduled dose; then omit the missed dose and resume the regular schedule. Never double the dose. Overdosage risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic agents, alcohol, or skipped meals may precipitate hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals require prior medical consultation. Renal function assessment will precede treatment commencement. Limit alcohol consumption to minimize the risk of adverse reactions.
Primary Ingredients of Metpath-GP2 Tablet SR
No text provided. Please provide the text you wish me to rewrite.
Uses of Metpath-GP2 Tablet SR
Managing type 2 diabetes
Major Benefits of Metpath-GP2 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metpath-GP2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Metpath-GP2 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metpath-GP2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Metpath-GP2 Tablet SR should be administered with a meal.
How Metpath-GP2 Tablet SR works:
Metpath-GP2 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Metpath-GP2 Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Metpath-GP2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Metpath-GP2 tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Metpath-GP2 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Metpath-GP2 Tablet SR is contraindicated in patients with severe kidney disease. Regular monitoring of kidney function is advised during treatment.
LiverCAUTION
Individuals with liver impairment should use Metpath-GP2 SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Metpath-GP2 SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Metpath-GP2 Tablet SR :
Should you forget a dose of Metpath-GP2 Tablet SR, take it immediately if you remember. But, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metpath-GP2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently